Text Size

Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00250809
First received: November 4, 2005
Last updated: January 6, 2010
Last verified: March 2009
History of Changes
  Purpose

CVC Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study


Condition Intervention
Other Female Genital
Cancer
 Procedure: Placement of a central venous catheter

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: CVC Pros and Cons of Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

Further study details as provided by University of New Mexico:

Primary Outcome Measures:
  • Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]

Enrollment: 15
Study Start Date: March 1994
Study Completion Date: March 2006
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Placement of a central venous catheter
    Placement of a central venous catheter
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

1. Patients who require the placement of a central venous catheter for medical purposes and have an absence of infection.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00250809

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico
  More Information

No publications provided

Responsible Party: Harriet Smith, MD; Principal Investigator, University of New Mexico - CRTC
ClinicalTrials.gov Identifier: NCT00250809     History of Changes
Other Study ID Numbers: CVC
Study First Received: November 4, 2005
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 16, 2013